In a further mechanistic study, it was concluded that TRIM2 can accelerate the progression of pancreatic cancer through the ROS-related NRF2/ITGB7/FAK axis, which reveals a new regulatory role of TRIM2 through the regulation of redox homeostasis and integration of independent signaling pathways. This evidence concerns the gene ITGB7 and pancreatic neoplasm.